Heme scavenging and the other facets of hemopexin

Antioxidants and Redox Signaling

Volumn 12, Issue 2, 2010, Pages 305-320

  Tolosano, Emanuela ^a   Fagoonee, Sharmila ^a   Morello, Noemi ^a   Vinchi, Francesca ^a   Fiorito, Veronica ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOPEXIN; HEMOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; HEME;

BINDING AFFINITY; BLOOD TOXICITY; CATABOLISM; CELL SURVIVAL; COMPLEX FORMATION; HEMOLYSIS; HUMAN; INFLAMMATION; INTRAHEPATIC BILE DUCT; KIDNEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RETINA; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; BIOLOGICAL MODEL; GENETICS; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; HEME; HEMOPEXIN; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; LIVER; MODELS, BIOLOGICAL; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 77949497609     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2787     Document Type: Review

References (136)

1. Abraham NG, Lin JH, Schwartzman ML, Levere RD, and Shibahara S. The physiological significance of heme oxy-genase. Int J Biochem 20: 543-558, 1988.
2. Alam J and Smith A. Heme-hemopexin-mediated induction of metallothionein gene expression. J B Chem 267: 16379-16384, 1992.
3. Alam J and Smith A. Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells. J Biol Chem 264: 17637-17640, 1989. (Pubitemid 19279220)
4. Arosio P and Levi S. Ferritin, iron homeostasis, and oxi-dative damage. Free Radic Biol Med 33: 457-463, 2002. (Pubitemid 34874967)
5. Ascenzi P, Bocedi A, Visca P, Altruda F, Tolosano E, Beringhelli T, and Fasano M. Hemoglobin and heme scavenging. IUBMB Life 57: 749-759, 2005. (Pubitemid 41781830)
6. Ascenzi P and Fasano M. Heme-hemopexin: a 'chron-osteric' heme-protein. IUBMB Life 59: 700-708, 2007.
7. Baker HM, Anderson BF, and Baker EN. Dealing with iron: common structural principles in proteins that transport iron and heme. Proc Natl Acad Sci USA 100: 3579-3583, 2003. (Pubitemid 36418076)
8. Bakker WW, Borghuis T, Harmsen MC, van den Berg A, Kema IP, Niezen KE, and Kapojos JJ. Protease activity of plasma hemopexin. Kidney Int 68: 603-610, 2005. (Pubitemid 43323115)
9. Bakker WW, van Dael CM, Pierik LJ, van Wijk JA, Nauta J, Borghuis T, and Kapojos JJ. Altered activity of plasma he-mopexin in patients with minimal change disease in relapse. Pediatr Nephrol (Berlin) 20: 1410-1415, 2005. (Pubitemid 41403414)
10. Balla G, Jacob HS, Eaton JW, Belcher JD, and Vercellotti GM. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Ar-terioscler Thromb 11: 1700-1711, 1991.
11. Balla J, Balla G, Jeney V, Kakuk G, Jacob HS, and Vercellotti GM. Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants. Blood 95: 3442-3450, 2000. (Pubitemid 30428475)
12. Beaumont C and Canonne-Hergaux F. [Erythrophagocy-tosis and recycling of heme iron in normal and pathological conditions; regulation by hepcidin]. Transfus Clin Biol 12: 123-130, 2005. (Pubitemid 40805057)
13. Belcher JD, Beckman JD, Balla G, Balla J, and Vercellotti G. Heme degradation and vascular injury. Antiox Redox Signal 12, 2010.
14. Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, Bischof JC, Hebbel RP, and Vercellotti GM. Transgenic sickle mice have vascular inflammation. Blood 101: 3953-3959, 2003. (Pubitemid 36857872)
15. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, and Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 116: 808-816, 2006. (Pubitemid 43326890)
16. Berg D and Youdim MB. Role of iron in neurodegenerative disorders. Topics Magn Reson Imaging 17: 5-17, 2006. (Pubitemid 46672929)
17. Beri R and Chandra R. Chemistry and biology of heme: effect of metal salts, organometals, and metalloporphyrins on heme synthesis and catabolism, with special reference to clinical implications and interactions with cytochrome P-450. Drug Metabol Rev 25: 49-52, 1993.
18. Bissell DM, Hammaker L, and Schmid R. Hemoglobin and erythrocyte catabolism in rat liver: the separate roles of parenchymal and sinusoidal cells. Blood 40: 812-822, 1972.
19. Boucher P, Gotthardt M, Li WP, Anderson RG, and Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science (New York) 300: 329-332, 2003. (Pubitemid 36433724)
20. Bowlus CL. The role of iron in T cell development and autoimmunity. Autoimmun Rev 2: 73-78, 2003. (Pubitemid 37443858)
21. Camborieux L, Bertrand N, and Swerts JP. Changes in expression and localization of hemopexin and its transcripts in injured nervous system: a comparison of central and peripheral tissues. Neuroscience 82: 1039-1052, 1998. (Pubitemid 27502049)
22. Camborieux L, Julia V, Pipy B, and Swerts JP. Respective roles of inflammation and axonal breakdown in the regulation of peripheral nerve hemopexin: an analysis in rats and in C57BL=Wlds mice. J Neuroimmunol 107:29-41, 2000. (Pubitemid 30243128)
23. Chen W, Lu H, Dutt K, Smith A, Hunt DM, and Hunt RC. Expression of the protective proteins hemopexin and hapto-globin by cells of the neural retina. Exp Eye Res 67:83-93, 1998. (Pubitemid 28364817)
24. Cheung PK, Klok PA, Baller JF, and Bakker WW. Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 57: 1512-1520, 2000. (Pubitemid 30207910)
25. Chiocchetti A, Tolosano E, Hirsch E, Silengo L, and Altruda F. Green fluorescent protein as a reporter of gene expression in transgenic mice. Biochim Biophys Acta 1352: 193-202, 1997. (Pubitemid 27261972)
26. Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, Ho PP, Lee LY, Sobel RA, Steinman L, and Soares MP. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clinl Invest 117: 438-447, 2007. (Pubitemid 46203972)
27. Connor JR and Menzies SL. Relationship of iron to oligo-dendrocytes and myelination. Glia 17: 83-93, 1996.
28. Conrad ME, Parmley RT, and Osterloh K. Small intestinal regulation of iron absorption in the rat. J Lab Clin Med 110: 418-426, 1987. (Pubitemid 18029906)
29. Cousins RJ, Liuzzi JP, and Lichten LA. Mammalian zinc transport, trafficking, and signals. J Biol Chem 281: 24085-24089, 2006. (Pubitemid 44274182)
30. Davidsson P, Folkesson S, Christiansson M, Lindbjer M, Dellheden B, Blennow K, and Westman-Brinkmalm A. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption=ionisation mass spectrom-etry. Rapid Commun Mass Spectrom 16: 2083-2088, 2002. (Pubitemid 35340074)
31. Davies DM, Smith A, Muller-Eberhard U, and Morgan WT. Hepatic subcellular metabolism of heme from heme-hemopexin: incorporation of iron into ferritin. Biochem Biophys Res Commun 91: 1504-1511, 1979. (Pubitemid 10143651)
32. Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, and Stopa EG. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuro-pathol 112: 405-415, 2006. (Pubitemid 44469161)
33. Engler R and Jayle MF. [Clinical value of the immuno-chemical determination of the plasma proteins]. Semin Hop 52: 2481-2484, 1976.
34. Eskew JD, Vanacore RM, Sung L, Morales PJ, and Smith A. Cellular protection mechanisms against extracellular heme. heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase. J Biol Chem 274: 638-648, 1999.
35. Fagoonee S, Caorsi C, Giovarelli M, Stoltenberg M, Silengo L, Altruda F, Camussi G, Tolosano E, and Bussolati B. Lack of plasma protein hemopexin dampens mercury-induced autoimmune response in mice. J Immunol 181: 1937-1947, 2008.
36. Fagoonee S, Di Cunto F, Vozzi D, Volinia S, Pellegrino M, Gasparini P, Silengo L, Altruda F, and Tolosano E. Micro-array and large-scale in silico-based identification of genes functionally related to haptoglobin and=or hemopexin. DNA Cell Biol 25: 323-330, 2006. (Pubitemid 43954562)
37. Fagoonee S, Gburek J, Hirsch E, Marro S, Moestrup SK, Laurberg JM, Christensen EI, Silengo L, Altruda F, and Tolosano E. Plasma protein haptoglobin modulates renal iron loading. Am J Pathol 166: 973-983, 2005. (Pubitemid 40524423)
38. Gardiner ME and Morgan EH. Transferrin and iron uptake by the liver in the rat. Aust J Exp Biol Med Sci 52: 723-736, 1974.
39. Graca-Souza AV, Arruda MA,deFreitasMS, Barja-Fidalgo C, and Oliveira PL. Neutrophil activation by heme: implications for inflammatory processes. Blood 99: 4160-4165, 2002. (Pubitemid 35332061)
40. Grinberg LN, O'Brien PJ, and Hrkal Z. The effects of heme-binding proteins on the peroxidative and catalytic activities of hemin. Free Radic Biol Med 27: 214-219, 1999. (Pubitemid 29353102)
41. Gutteridge JM and Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Bio-chem J 256: 861-865, 1988. (Pubitemid 19021714)
42. Hentze MW, Muckenthaler MU, and Andrews NC. Balancing acts; molecular control of mammalian iron metabolism. Cell 117: 285-297, 2004. (Pubitemid 38534536)
43. Higa Y, Oshiro S, Kino K, Tsunoo H, and Nakajima H. Catabolism of globin-haptoglobin in liver cells after intravenous administration of hemoglobin-haptoglobin to rats. J Biol Chem 256: 12322-12328, 1981. (Pubitemid 12140023)
44. Hu K, Yang J, Tanaka S, Gonias SL, Mars WM, and Liu Y. Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J Biol Chem 281: 2120-2127, 2006. (Pubitemid 43845801)
45. Hunt RC, Handy I, and Smith A. Heme-mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin. J Cell Physiol 168: 81-86, 1996. (Pubitemid 26233435)
46. Hunt RC, Hunt DM, Gaur N, and Smith A. Hemopexin in the human retina: protection of the retina against heme-mediated toxicity. J Cell Physiol 168: 71-80, 1996. (Pubitemid 26233434)
47. Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, and Moestrup SK. Identification of the receptor scavenging hemopexin-heme complexes. Blood 106: 2572-2579, 2005. (Pubitemid 41510836)
48. Igarashi K, Itoh K, Hayashi N, Nishizawa M, and Yamamoto M. Conditional expression of the ubiquitous transcription factor MafK induces erythroleukemia cell differentiation. Proc Natl Acad Sci USA 92: 7445-7449, 1995.
49. Igarashi K, Itoh K, Motohashi H, Hayashi N, Matuzaki Y, Nakauchi H, Nishizawa M, and Yamamoto M. Activity and expression of murine small Maf family protein MafK. J Biol Chem 270: 7615-7624, 1995.
50. Igarashi K, Kataoka K, Itoh K, Hayashi N, Nishizawa M, and Yamamoto M. Regulation of transcription by dimer-ization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 367: 568-572, 1994. (Pubitemid 24055517)
51. Immenschuh S, Song DX, Satoh H, and Muller-Eberhard U. The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemo-pexin acute phase responsiveness. Biochem Biophys Res Commun 207: 202-208, 1995.
52. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, and Yamamoto M. Transcription factor Nrf2 co-ordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275: 16023-16029, 2000. (Pubitemid 30366908)
53. Ishikawa M, Numazawa S, and Yoshida T. Redox regulation of the transcriptional repressor Bach1. Free Radic Biol Med 38: 1344-1352, 2005. (Pubitemid 40602836)
54. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, and Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887, 2002. (Pubitemid 34832613)
55. Kapojos JJ, van den Berg A, van Goor H, te Loo MW, Poelstra K, Borghuis T, and Bakker WW. Production of hemopexin by TNF-alpha stimulated human mesangial cells. Kidney Int 63: 1681-1686, 2003. (Pubitemid 36513313)
56. Keel SB, Doty RT, Yang Z, Quigley JG, Chen J, Knoblaugh S, Kingsley PD, De Domenico I, Vaughn MB, Kaplan J, Palis J, and Abkowitz JL. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science (New York) 319: 825-828, 2008. (Pubitemid 351225875)
57. Kino K, Mizumoto K, Watanabe J, and Tsunoo H. Im-munohistochemical studies on hemoglobin-haptoglobin and hemoglobin catabolism sites. J Histochem Cytochem 35: 381-386, 1987. (Pubitemid 17018504)
58. Kitamuro T, Takahashi K, Ogawa K, Udono-Fujimori R, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, and Shibahara S. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278: 9125-9133, 2003. (Pubitemid 36800393)
59. Kotze MJ, de Villiers JN, Rooney RN, Grobbelaar JJ, Man-svelt EP, Bouwens CS, Carr J, Stander I, and du Plessis L. Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. Blood Cells Mol Dis 27: 44-53, 2001. (Pubitemid 32299753)
60. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, and Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 409: 198-201, 2001. (Pubitemid 32144285)
61. Kumar S and Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 157: 175-188, 2005. (Pubitemid 40726102)
62. Kuvibidila S, Nauss KM, Baliga BS, and Suskind RM. Impairment of blastogenic response of splenic lymphocytes from iron-deficient mice: in vivo repletion. Am J Clin Nutr 37: 15-25, 1983. (Pubitemid 13155493)
63. Kyriakis JM and Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18: 567-577, 1996. (Pubitemid 26311096)
64. LaBadie JH, Chapman KP, and Aronson NN Jr. Glyco-protein catabolism in rat liver: lysosomal digestion of io-dinated asialo-fetuin. Biochem J 152: 271-279, 1975.
65. Lane RS, Rangeley DM, Liem H, Wormsley S, and Muller-Eberhard U. Hemopexin metabolism in the rabbit. J Lab Clin Med 79: 935-941, 1972.
66. Lane RS, Rangeley DM, Liem HH, Wormsley S, and Muller-Eberhard U. Plasma clearance of 125I-labelled hae-mopexin in normal and haem-loaded rabbits. Br J Haematol 25: 533-540, 1973.
67. Latunde-Dada GO, Simpson RJ, and McKie AT. Recent advances in mammalian haem transport. Trends Biochem Sci 31: 182-188, 2006. (Pubitemid 43357998)
68. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, and Abraham NG. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 91: 5987-5991, 1994. (Pubitemid 24188267)
69. Leiter LM, Reuhl KR, Racis SP Jr, and Sherman AR. Iron status alters murine systemic lupus erythematosus. J Nutr 125: 474-484, 1995.
70. Lennon R, Singh A, Welsh GI, Coward RJ, Satchell S, Ni L, Mathieson PW, Bakker WW, and Saleem MA. Hemopexin induces nephrin-dependent reorganization of the actin cyto-skeleton in podocytes. J Am Soc Nephrol 19: 2140-2149, 2008.
71. Liem HH, Spector JI, Conway TP, Morgan WT, and Muller-Eberhard U. Effect of hemoglobin and hematin on plasma clearance of hemopexin, photo-inactivated hemopexin and albumin (38575). Proc Soc Exp Biol Med Soc (New York) 148: 519-522, 1975.
72. Lillis AP, Mikhailenko I, and Strickland DK. Beyond en-docytosis: LRP function in cell migration, proliferation and vascular permeability. J Thromb Haemost 3: 1884-1893, 2005. (Pubitemid 41716576)
73. Lim SK, Kim H, bin Ali A, Lim YK, Wang Y, Chong SM, Costantini F, and Baumman H. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 92: 1870- 1877, 1998. (Pubitemid 28446675)
74. Loukinova E, Ranganathan S, Kuznetsov S, Gorlatova N, Migliorini MM, Loukinov D, Ulery PG, Mikhailenko I, Lawrence DA, and Strickland DK. Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP): evidence for integrated co-receptor function between LRP and the PDGF. J Biol Chem 277: 15499-15506, 2002. (Pubitemid 34967816)
75. Madore N, Camborieux L, Bertrand N, and Swerts JP. Regulation of hemopexin synthesis in degenerating and regenerating rat sciatic nerve. J Neurochem 72: 708-715, 1999. (Pubitemid 29055234)
76. Maines MD and Panahian N. The heme oxygenase system and cellular defense mechanisms: do HO-1 and HO-2 have different functions? Adv Exp Med Biol 502: 249-272, 2001. (Pubitemid 34234060)
77. Marro S, Barisani D, Chiabrando D, Fagoonee S, Muck-enthaler MU, Stolte J, Meneveri R, Haile D, Silengo L, Al-truda F, and Tolosano E. Lack of haptoglobin affects iron transport across duodenum by modulating ferroportin expression. Gastroenterology 133: 1261-1271, 2007.
78. Mauk MR, Rosell FI, Lelj-Garolla B, Moore GR, and Mauk AG. Metal ion binding to human hemopexin. Biochemistry 44: 1864-1871, 2005. (Pubitemid 40223617)
79. Mehta D and Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279-367, 2006.
80. Mense SM and Zhang L. Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases. Cell Res 16: 681-692, 2006. (Pubitemid 44258921)
81. Miller YI, Smith A, Morgan WT, and Shaklai N. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. Biochemistry 35: 13112-13117, 1996. (Pubitemid 26349462)
82. Montellano PR. The mechanism of heme oxygenase. Curr Opin Chem Biol 4: 221-227, 2000. (Pubitemid 30189315)
83. Morello N, Tonoli E, Logrand F, Fiorito V, Fagoonee S, Turco E, Silengo L, Vercelli A, Altruda F, and Tolosano E. Hemopexin affects iron distribution and ferritin expression in mouse brain. J Cell Mol Med 2008. DOI. 10.1111=j.1582-4934.2008.00611.x
84. Morgan WT. The binding and transport of heme by he-mopexin. Ann Clin Res 8(suppl 17): 223-232, 1976.
85. Morgan WT, Liem HH, Sutor RP, and Muller-Ebergard U. Transfer of heme from heme-albumin to hemopexin. Bio-chim Biophys Acta 444: 435-445, 1976.
86. Morris CM, Candy JM, Edwardson JA, Bloxham CA, and Smith A. Evidence for the localization of haemopexin im-munoreactivity in neurones in the human brain. Neurosci Lett 149: 141-144, 1993. (Pubitemid 23036900)
87. Muller-Eberhard U. Hemopexin. N Engl J Med 283: 1090-1094, 1970.
88. Muller-Eberhard U, Javid J, Liem HH, Hanstein A, and Hanna M. Plasma concentrations of hemopexin, haptoglo-bin and heme in patients with various hemolytic diseases. Blood 32: 811-815, 1968.
89. Newton CS, Loukinova E, Mikhailenko I, Ranganathan S, Gao Y, Haudenschild C, and Strickland DK. Platelet-derived growth factor receptor-beta (PDGFR-beta) activation promotes its association with the low density lipoprotein receptor-related protein (LRP): evidence for co-receptor function. J Biol Chem 280: 27872-27878, 2005. (Pubitemid 41076904)
90. Pao SS, Paulsen IT, and Saier MH Jr. Major facilitator su-perfamily. Microbiol Mol Biol Rev 62: 1-34, 1998.
91. Porath J and Olin B. Immobilized metal ion affinity adsorption and immobilized metal ion affinity chromatography of biomaterials: serum protein affinities for gel-immobilized iron and nickel ions. Biochemistry 22: 1621-1630, 1983.
92. Porto G and De Sousa M. Iron overload and immunity. World J Gastroenterol 13: 4707-4715, 2007. (Pubitemid 47455561)
93. Potter D, Chroneos ZC, Baynes JW, Sinclair PR, Gorman N, Liem HH, Muller-Eberhard U, and Thorpe SR. In vivo fate of hemopexin and heme-hemopexin complexes in the rat. Arch Biochem Biophys 300: 98-104, 1993. (Pubitemid 23225723)
94. Quigley JG, Yang Z, Worthington MT, Phillips JD, Sabo KM, Sabath DE, Berg CL, Sassa S, Wood BL, and Abkowitz JL. Identification of a human heme exporter that is essential for erythropoiesis. Cell 118: 757-766, 2004. (Pubitemid 39221734)
95. Regis G, Bosticardo M, Conti L, De Angelis S, Boselli D, Tomaino B, Bernabei P, Giovarelli M, and Novelli F. Iron regulates T-lymphocyte sensitivity to the IFN-gamma= STAT1 signaling pathway in vitro and in vivo. Blood 105: 3214-3221, 2005.
96. Regis G, Conti L, Boselli D, and Novelli F. IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes. Trends Immunol 27: 96-101, 2006. (Pubitemid 43221976)
97. Ren Y and Smith A. Mechanism of metallothionein gene regulation by heme-hemopexin: roles of protein kinase C, reactive oxygen species, and cis-acting elements. J Biol Chem 270: 23988-23995, 1995.
98. Ryter SW and Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity: heme oxyge-nase has both pro- and antioxidant properties. Free Radic Biol Med 28: 289-309, 2000. (Pubitemid 30084022)
99. Sawitsky B, Kanter R, and Sawitsky A. Lymphocyte response to phytomitogens in iron deficiency. Am J Med Sci 272: 153-160, 1976. (Pubitemid 8032592)
100. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, and McKie AT. Identification of an intestinal heme transporter. Cell 122: 789-801, 2005. (Pubitemid 41242642)
101. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, and Zlokovic BV. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-1499, 2000. (Pubitemid 32038587)
102. Shipulina N, Hunt RC, Shaklai N, and Smith A. Coordination of nitric oxide by heme-hemopexin. J Protein Chem 17: 255-260, 1998. (Pubitemid 28194489)
103. Sinclair PR, Bement WJ, Gorman N, Liem HH, Wolkoff AW, and Muller-Eberhard U. Effect of serum proteins on haem uptake and metabolism in primary cultures of liver cells. Biochem J 256: 159-165, 1988.
104. Smith A, Eskew JD, Borza CM, Pendrak M, and Hunt RC. Role of heme-hemopexin in human T-lymphocyte proliferation. Exp Cell Res 232: 246-254, 1997. (Pubitemid 27194036)
105. Smith A and Ledford BE. Expression of the haemopexin-transport system in cultured mouse hepatoma cells: links between haemopexin and iron metabolism. Biochem J 256: 941-950, 1988. (Pubitemid 19021726)
106. Smith A and Morgan WT. Haem transport to the liver by haemopexin: receptor-mediated uptake with recycling of the protein. Biochem J 182: 47-54, 1979. (Pubitemid 9240663)
107. Smith A and Morgan WT. Hemopexin-mediated heme uptake by liver: characterization of the interaction of heme-hemopexin with isolated rabbit liver plasma membranes. J Biol Chem 259: 12049-12053, 1984. (Pubitemid 14022137)
108. Smith A and Morgan WT. Hemopexin-mediated transport of heme into isolated rat hepatocytes. J Biol Chem 256: 10902-10909, 1981.
109. Smith A and Morgan WT. Transport of heme by hemo-pexin to the liver: evidence for receptor-mediated uptake. Biochem Biophys Res Commun 84: 151-157, 1978. (Pubitemid 9015299)
110. Smith A, Rish KR, Lovelace R, Hackney JF, and Helston RM. Role for copper in the cellular and regulatory effects of heme-hemopexin. Biometals 22: 421-437, 2009.
111. Soyano A, Candellet D, and Layrisse M. Effect of iron deficiency on the mitogen-induced proliferative response of rat lymphocytes. Int Arch Allergy Appl Immunol 69: 353-357, 1982. (Pubitemid 13208231)
112. Stoll G, Griffin JW, Li CY, and Trapp BD. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 18: 671-683, 1989. (Pubitemid 20001442)
113. Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, and Igarashi K. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 21: 5216-5224, 2002.
114. Swerts JP, Soula C, Sagot Y, Guinaudy MJ, Guillemot JC, Ferrara P, Duprat AM, and Cochard P. Hemopexin is synthesized in peripheral nerves but not in central nervous system and accumulates after axotomy. J Biol Chem 267: 10596-10600, 1992.
115. Tailor CS, Willett BJ, and Kabat D. A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol 73: 6500-6505, 1999. (Pubitemid 29327830)
116. Taketani S, Immenschuh S, Go S, Sinclair PR, Stockert RJ, Liem HH, and Muller Eberhard U. Hemopexin from four species inhibits the association of heme with cultured hepatoma cells or primary rat hepatocytes exhibiting a small number of species specific hemopexin receptors. Hepatology (Baltimore, Md) 27: 808-814, 1998. (Pubitemid 28103559)
117. Taketani S, Kohno H, Sawamura T, and Tokunaga R. Hemopexin-dependent down-regulation of expression of the human transferrin receptor. J Biol Chem 265: 13981-13985, 1990.
118. Timmins GS, Davies MJ, and Muller-Eberhard U. A study of the effects of complexation of heme by hemopexin upon its reactions with organic peroxides. Biochem Soc Trans 23: 244S, 1995.
119. Tolosano E and Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol 21: 297-306, 2002. (Pubitemid 34594543)
120. Tolosano E, Cutufia MA, Hirsch E, Silengo L, and Altruda F. Specific expression in brain and liver driven by the he-mopexin promoter in transgenic mice. Biochem Biophys Res Commun 218: 694-703, 1996. (Pubitemid 26050725)
121. Tolosano E, Fagoonee S, Hirsch E, Berger FG, Baumann H, Silengo L, and Altruda F. Enhanced splenomegaly and severe liver inflammation in haptoglobin=hemopexin double-null mice after acute hemolysis. Blood 100: 4201-4208, 2002. (Pubitemid 35402055)
122. Tolosano E, Hirsch E, Patrucco E, Camaschella C, Navone R, Silengo L, and Altruda F. Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Blood 94: 3906-3914, 1999.
123. Trommsdorff M, Borg JP, Margolis B, and Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipo-protein E receptors and the amyloid precursor protein. J Biol Chem 273: 33556-33560, 1998. (Pubitemid 29005740)
124. Vincent SH, Grady RW, Shaklai N, Snider JM, and Muller-Eberhard U. The influence of heme-binding proteins in heme-catalyzed oxidations. Arch Biochem Biophys 265: 539-550, 1988.
125. Vinchi F, Gastaldi S, Silengo L, Altruda F, and Tolosano E. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol 173: 289-299, 2008. (Pubitemid 351947975)
126. Wagener FA, Abraham NG, van Kooyk Y, de Witte T, and Figdor CG. Heme-induced cell adhesion in the pathogen-esis of sickle-cell disease and inflammation. Trends Pharmacol Sci 22: 52-54, 2001. (Pubitemid 32146473)
127. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, and Figdor CG. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802-1811, 2001.
128. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, and Figdor CG. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55: 551-571, 2003. (Pubitemid 37013215)
129. Ward JH, Jordan I, Kushner JP, and Kaplan J. Heme regulation of HeLa cell transferrin receptor number. J Biol Chem 259: 13235-13240, 1984. (Pubitemid 15223847)
130. Weinstein MB and Segal HL. Uptake of free hemoglobin by rat liver parenchymal cells. Biochem Biophys Res Commun 123: 489-496, 1984. (Pubitemid 14010123)
131. Wijayanti N, Katz N, and Immenschuh S. Biology of heme in health and disease. Curr Med Chem 11: 981-986, 2004. (Pubitemid 38428649)
132. Wochner RD, Spilberg I, Iio A, Liem HH, and Muller-Eberhard U. Hemopexin metabolism in sickle-cell disease, porphyrias and control subjects: effects of heme injection. N Engl J Med 290: 822-826, 1974.
133. Yamasaki C, Tashiro S, Nishito Y, Sueda T, and Igarashi K. Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP. J Biochem 137: 287-296, 2005. (Pubitemid 40628434)
134. Yang Z, Doty RT, Nguyen MH, Smith A, and Abkowitz JL. Evidence that Heme export via the feline leukemia virus, subgroup, C receptor (FLVCR) is carrier dependent and its physiological implications. Blood (ASH Annual Meeting) 110: 2659, 2007.
135. Zecca L, Youdim MB, Riederer P, Connor JR, and Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873, 2004. (Pubitemid 39482155)
136. Zhang C, An J, Strickland DK, and Yepes M. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am J Pathol 174: 586-594, 2009.